iOS app Android app

Drug Research

The DEA: Four Decades of Impeding and Rejecting Science

Ethan Nadelmann | Posted 08.10.2014 | Politics
Ethan Nadelmann

It's increasingly clear that entrusting decisions involving medical science to the DEA is akin to leaving the fox in charge of the henhouse. And what's most striking is how little scrutiny the DEA has faced from Congress or other federal overseers.

Misleading 'Models' Stymie Drug Research, Researcher Says

natureheader | Erika Check Hayden | Posted 03.27.2014 | Science

A running joke among health researchers is that everything has been cured — in mice. However that may not be always true.The failure of experimental...

The Economics of Cancer: Learning From India About Innovation

Matthew Kavanagh | Posted 06.05.2013 | Healthy Living
Matthew Kavanagh

But what if you want to incentivize investment in bold new drugs instead of me-too drugs? What if you want to encourage research into new areas that tangibly improve people's health? Then maybe, like India, you would only grant patents when that higher standard is met.

Fighting Cancer: Better Models Make Better Drugs

Beth Hollister | Posted 03.25.2013 | Science
Beth Hollister

The realities of pharmaceutical research are brutal, consisting of decade-and-a-half long timescales, mind-numbing costs and exceedingly long, soul-crushing odds of success. In the fight against cancer, this rings especially true.

Government To Start Billion-Dollar Research Center To Develop New Medicines

New York Times | Posted 05.25.2011 | Home

The Obama administration has become so concerned about the slowing pace of new drugs coming out of the pharmaceutical industry that officials have dec...

Definition of Affordable

Richard Chin | Posted 05.25.2011 | World
Richard Chin

We believe we can develop drugs much less expensively than big pharma. We don't have some of the constraints they do, and at iOWH, and we have had a lot of success in driving costs down.

Drug Companies Share Data To Speed Brain Research

AP | Posted 11.17.2011 | Healthy Living

WASHINGTON — In an unusual step, a dozen competing drug companies have agreed to share data on thousands of Alzheimer's patients in hopes that t...